Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-azidoethyl (5-acetamido-9-(2-benzyl-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamido)-3,5,9-trideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid)-(2→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-Dglucopyranoside is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1397938-28-1

Post Buying Request

1397938-28-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-azidoethyl (5-acetamido-9-(2-benzyl-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamido)-3,5,9-trideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid)-(2→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-Dglucopyranoside

    Cas No: 1397938-28-1

  • Need to discuss

  • No requirement

  • Adequate

  • Xiamen AmoyChem Co.,Ltd
  • Contact Supplier
  • 2-azidoethyl (5-acetamido-9-(2-benzyl-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamido)-3,5,9-trideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid)-(2→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-Dglucopyranoside

    Cas No: 1397938-28-1

  • Need to discuss

  • No requirement

  • Adequate

  • Wuhan Circle Star Chem-medical Technology co.,Ltd.
  • Contact Supplier

1397938-28-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1397938-28-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,7,9,3 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1397938-28:
(9*1)+(8*3)+(7*9)+(6*7)+(5*9)+(4*3)+(3*8)+(2*2)+(1*8)=231
231 % 10 = 1
So 1397938-28-1 is a valid CAS Registry Number.

1397938-28-1Downstream Products

1397938-28-1Relevant articles and documents

In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages

Nycholat, Corwin M.,Rademacher, Christoph,Kawasaki, Norihito,Paulson, James C.

, p. 15696 - 15699,4 (2020/08/24)

Cell-specific delivery of therapeutic agents using ligand targeting is gaining interest because of its potential for increased efficacy and reduced side effects. The challenge is to develop a suitable ligand for a cell-surface receptor that is selectively

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1397938-28-1